Sign Up to like & get recommendations! 0
Published in 2022 at "Clinical and Translational Allergy"
DOI: 10.1002/clt2.12176
Abstract: Abstract Background Lebrikizumab is a monoclonal antibody that modulates activity of interleukin‐13. The Phase 3 ACOUSTICS study assessed lebrikizumab efficacy and safety in adolescents with uncontrolled asthma despite standard‐of‐care treatment. Methods Adolescents (aged 12–17 years)… read more here.
Sign Up to like & get recommendations! 2
Published in 2022 at "Journal of clinical laboratory analysis"
DOI: 10.1002/jcla.24345
Abstract: This study aims to evaluate markers of oxidative stress in Tunisian asthmatic patients and investigate whether their markers are correlated with uncontrolled asthma. This prospective cohort study was conducted on 48 healthy subjects and 60 patients… read more here.
Sign Up to like & get recommendations! 2
Published in 2022 at "Pediatric Pulmonology"
DOI: 10.1002/ppul.26170
Abstract: Peripheral airway impairment (PAI) has been shown to have a close association to risk of uncontrolled asthma in children. However, clear methods have not been established for the clinician to select impulse oscillometry (IOS) reference… read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "Pediatric pulmonology"
DOI: 10.1002/ppul.26457
Abstract: BACKGROUND Children from economically disadvantaged communities often encounter healthcare access barriers, increasing risk for poorly controlled asthma and subsequent healthcare utilization. This highlights the need to identify novel intervention strategies for these families. OBJECTIVE To… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Advances in Therapy"
DOI: 10.1007/s12325-024-02889-8
Abstract: Many patients with severe asthma continue to experience symptoms and exacerbations despite treatment with standard-of-care therapy. In the phase 3 NAVIGATOR study, tezepelumab significantly reduced exacerbations over 52 weeks compared with placebo in patients with… read more here.
Sign Up to like & get recommendations! 2
Published in 2020 at "Journal of Asthma"
DOI: 10.1080/02770903.2020.1713150
Abstract: Abstract Objective: To study asthma exacerbations, healthcare utilization and health status among subjects with asthma with different treatment regimens and levels of asthma control. Methods: In 2012–2014, n = 1425 adults from a population-based asthma cohort within… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Journal of Asthma"
DOI: 10.1080/02770903.2024.2441881
Abstract: Abstract Background The ultimate goal of asthma management is to have complete control of the condition, yet the number of patients with uncontrolled asthma continues to rise. This study aims to determine the prevalence of… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Current Medical Research and Opinion"
DOI: 10.1080/03007995.2017.1354828
Abstract: Abstract Background: Fibromyalgia can affect the control of asthma when both diseases are present in a single patient. Objectives: To characterize asthma in patients with concomitant fibromyalgia to assess whether fibromyalgia is an independent factor… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2017.1319472
Abstract: ABSTRACT Introduction: Smooth muscle cell contraction in the airways is the principal therapeutic target in asthmatic subjects and its insufficient treatment is often a cause of uncontrolled disease. For this reason, research has focused on… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2019.1672657
Abstract: ABSTRACT Introduction: Thymic stromal lymphopoietin (TSLP) is overexpressed in the airways of severe asthmatics and is an upstream cytokine that orchestrates inflammatory responses in asthma. TSLP exerts its effects by binding to a high affinity… read more here.
Sign Up to like & get recommendations! 1
Published in 2023 at "Expert review of clinical immunology"
DOI: 10.1080/1744666x.2023.2214363
Abstract: INTRODUCTION Asthma is a heterogenous, multifactorial disease with multiple genetic and environmental risk factors playing a role in pathogenesis and therapeutic response. Understanding of pharmacogenetics can help with matching individualized treatments to specific genotypes of… read more here.